Vivos Therapeutics v. Ortho-Tain ( 2022 )


Menu:
  • Appellate Case: 21-1309     Document: 010110699363       Date Filed: 06/21/2022     Page: 1
    FILED
    United States Court of Appeals
    UNITED STATES COURT OF APPEALS                          Tenth Circuit
    FOR THE TENTH CIRCUIT                            June 21, 2022
    _________________________________
    Christopher M. Wolpert
    Clerk of Court
    VIVOS THERAPEUTICS, INC.,
    Plaintiff - Appellee,
    v.                                                           No. 21-1309
    (D.C. No. 1:20-CV-01634-WJM-SKC)
    ORTHO-TAIN, INC.,                                             (D. Colo.)
    Defendant - Appellant.
    _________________________________
    ORDER AND JUDGMENT*
    _________________________________
    Before BACHARACH, BALDOCK, and EID, Circuit Judges.
    _________________________________
    In this interlocutory appeal, Ortho-Tain, Inc. (OT), challenges a district court
    order denying its motion to dismiss based in part on absolute immunity. OT also
    invokes our pendent appellate jurisdiction to review other non-final rulings in the
    district court’s order. To the extent the denial of immunity turns on a legal question,
    we have jurisdiction under the collateral order doctrine and reverse and remand for
    further proceedings. We dismiss the balance of the appeal for lack of jurisdiction.
    *
    After examining the briefs and appellate record, this panel has determined
    unanimously to honor the parties’ request for a decision on the briefs without oral
    argument. See Fed. R. App. P. 34(f); 10th Cir. R. 34.1(G). The case is therefore
    submitted without oral argument. This order and judgment is not binding precedent,
    except under the doctrines of law of the case, res judicata, and collateral estoppel. It
    may be cited, however, for its persuasive value consistent with Fed. R. App. P. 32.1
    and 10th Cir. R. 32.1.
    Appellate Case: 21-1309     Document: 010110699363         Date Filed: 06/21/2022     Page: 2
    I. Background
    The parties are competing manufacturers of dental devices. According to the
    amended complaint and attached exhibits, in April 2020, OT’s CEO, Leslie Stevens,
    sent a letter to Benco Dental Supply, which is an affiliate of Vivos Therapeutics, Inc.,
    accusing Benco of hosting seminars where Vivos misrepresented OT’s products as its
    own. In a series of communications that followed (collectively, the “Spring 2020
    Communications”), OT’s lawyer, Nathan Neff, repeatedly stated that Vivos and
    Benco were violating state and federal law, including the Lanham Act, 
    15 U.S.C. § 1125
    (a), which provides a cause of action for false advertising, see Bimbo Bakeries
    USA, Inc. v. Sycamore, 
    29 F.4th 630
    , 643 (10th Cir. 2022). Neff demanded that
    Benco notify seminar attendees of the alleged misrepresentations, cited legal
    authority for OT’s position, and at least implicitly, if not explicitly, threatened legal
    action. Indeed, on June 1, 2020, Neff sent Benco a draft complaint, which he later
    filed (with revisions) in the Northern District of Illinois, naming Vivos and Benco as
    defendants. And in a June 3 letter captioned, “Settlement Discussions – Lanham Act
    Violations,” Aplt. App. at 224, Neff asserted he was “privileged to defame” so long
    as his statements related to the proposed legal claims, 
    id. at 226
    .
    Vivos filed this suit several days later, asserting claims for libel per se, slander
    per se, intentional interference with contractual relations, and declaratory relief that it
    had not violated the Lanham Act. The following month, OT filed its complaint in the
    Northern District of Illinois against Vivos, Benco, and others. Thereafter, the district
    court here dismissed Vivos’s complaint with leave to amend. Meanwhile, in
    2
    Appellate Case: 21-1309    Document: 010110699363         Date Filed: 06/21/2022    Page: 3
    December 2020, OT’s sales department sent emails (“December 2020 emails”) to
    dentist-clients of Vivos, disparaging Vivos and its products. Consequently, when
    Vivos filed its amended complaint, it reasserted its previous claims and added two
    new claims for violations of the Lanham Act and the Colorado Consumer Protection
    Act (CCPA). The following lists Vivos’s claims and the conduct upon which they
    were predicated:
    Count 1: Lanham Act based on the December 2020 emails (and other
    online material).
    Count 2: CCPA based on the December 2020 emails.
    Count 3: Libel per se based on the Spring 2020 Communications and
    the December 2020 emails.
    Count 4: Slander per se based on the Spring 2020 Communications.
    Count 5: Intentional interference with contractual relations based on the
    Spring 2020 Communications and the December 2020 emails.
    Count 6: Declaratory judgment that it had not violated the Lanham Act.
    OT moved to dismiss, contending it had absolute immunity from any claims
    based on the Spring 2020 Communications because they related to the Northern
    District of Illinois litigation and as such were privileged. OT also argued that the
    claims under the Lanham Act and the CCPA should be dismissed or stricken as
    improper supplemental pleadings, that the entire amended complaint should be
    dismissed for impermissibly incorporating allegations into subsequent counts, and
    that the declaratory judgment claim should be dismissed as an improper anticipatory
    filing intended to preempt the Northern District of Illinois litigation. The district
    court rejected OT’s arguments, denied the motion to dismiss, and directed the parties
    3
    Appellate Case: 21-1309    Document: 010110699363            Date Filed: 06/21/2022   Page: 4
    to schedule a status conference. Instead, OT filed this appeal. Vivos then moved to
    dismiss this appeal for lack of jurisdiction. The parties have fully briefed the
    jurisdictional and merits issues. The Northern District of Illinois litigation has been
    stayed pending the outcome of this appeal and the underlying district court action or
    until the Northern District of Illinois removes the stay.
    I. Appellate Jurisdiction
    We first consider our jurisdiction. Generally, an order denying immunity
    qualifies for immediate review under the collateral order doctrine to the extent it
    turns on an issue of law. See Mitchell v. Forsyth, 
    472 U.S. 511
    , 530 (1985). Indeed,
    in Robinson v. Volkswagenwerk AG, we recognized that the collateral order doctrine
    permits immediate appellate review of an interlocutory order denying a motion to
    dismiss based on a claim of absolute immunity under the litigation privilege. See
    
    940 F.2d 1369
    , 1370 (10th Cir. 1991). We therefore proceeded to the merits and
    observed that “[a]ll lawyers are protected by an absolute privilege against defamation
    actions based upon litigation conduct in judicial proceedings.” 
    Id. at 1372
    .
    OT invokes essentially the same litigation privilege recognized in Robinson.
    Ordinarily, we would have jurisdiction to review this type of interlocutory appeal
    from the district court’s denial of immunity.1 However, “[i]f a district court cannot
    1
    In challenging OT’s analogy to the qualified immunity context, Vivos
    contends the denial of immunity is not immediately appealable because OT’s
    assertion of immunity does not extend to all of its claims. See Mot. to Dismiss at
    8-9; Mot. to Dismiss Reply Br. at 5-6. But even in the qualified immunity context,
    the “right to immunity is a right to immunity from certain claims, not from litigation
    in general; when immunity with respect to those claims has been finally denied,
    4
    Appellate Case: 21-1309     Document: 010110699363        Date Filed: 06/21/2022     Page: 5
    rule on the merits of [an] . . . immunity defense at the dismissal stage because the
    allegations in the pleadings are insufficient as to some factual matter, the district
    court’s determination is not immediately appealable.” Weise v. Casper, 
    507 F.3d 1260
    , 1264 (10th Cir. 2007).
    Here, the district court rejected OT’s immunity claim in part because the
    pleadings were insufficient to make a predicate factual determination. Distinguishing
    between the letter written by OT’s CEO, Leslie Stevens, and the communications
    from OT’s attorney, Nathan Neff, the district court determined that the litigation
    privilege protects an attorney’s prelitigation statements only if they relate to litigation
    contemplated in good faith. See Begley v. Ireson, 
    399 P.3d 777
    , 781 (Colo. App.
    2017) (“[F]or a litigation privilege to apply to an attorney’s prelitigation statement,
    not only must that statement be related to prospective litigation, but the litigation
    must be contemplated in good faith.”). Yet the district court declined to make any
    finding as to Neff’s good faith, stating, “[g]iven that this action is at the pleading
    stage, and that the Court must construe the allegations in the light most favorable to
    Vivos, the Court declines to delve into the factfinding endeavor of whether [Neff]
    made these communications in good faith contemplation of litigation.” Aplt. App. at
    351-52. Although the district court did not expressly say the pleadings were
    inadequate to make a finding as to good-faith, it noted the good-faith requirement and
    declined to make the necessary factual finding. Clearly, then, the district court found
    appeal must be available, and cannot be foreclosed by the mere addition of other
    claims to the suit,” Behrens v. Pelletier, 
    516 U.S. 299
    , 312 (1996).
    5
    Appellate Case: 21-1309    Document: 010110699363        Date Filed: 06/21/2022       Page: 6
    the pleadings insufficient. It follows that the denial of immunity for Neff’s
    statements does not turn on a legal question and thus it is not immediately
    appealable. See Weise, 
    507 F.3d at 1264
    . Accordingly, we dismiss the appeal to the
    extent it challenges that ruling. However, as explained below, we retain jurisdiction
    to review the denial of immunity for Stevens’ letter because that ruling turned solely
    on a legal question.
    II. Immunity
    The district court denied immunity as to Stevens’ statements, reasoning that,
    under Colorado law, the litigation privilege does not apply to non-attorney parties.
    We review de novo this legal determination regarding the applicability of absolute
    immunity. Robinson, 
    940 F.2d at 1370
    . Because the relevant claims arise under
    diversity jurisdiction, we apply Colorado law to resolve the immunity question. See
    Brokers’ Choice of Am., Inc. v. NBC Universal, Inc., 
    757 F.3d 1125
    , 1136 (10th Cir.
    2014); see also Aspen Orthopaedics & Sports Med., LLC v. Aspen Valley Hosp. Dist.,
    
    353 F.3d 832
    , 837 (10th Cir. 2003) (“[S]tate law governs the applicability of
    immunity to state law claims.” (internal quotation marks omitted)).
    Colorado has adopted the Restatement (Second) of Torts, both as to attorneys,
    § 586; see BKP, Inc. v. Killmer, Lane & Newman, LLP, 
    506 P.3d 84
    , 90 (Colo. App.
    2021), and parties, § 587; see Dep’t of Admin. v. State Pers. Bd., 
    703 P.2d 595
    ,
    597-98 (Colo. App. 1985). Under § 586 of the Restatement:
    An attorney at law is absolutely privileged to publish defamatory matter
    concerning another in communications preliminary to a proposed
    judicial proceeding, or in the institution of, or during the course and as a
    6
    Appellate Case: 21-1309     Document: 010110699363        Date Filed: 06/21/2022        Page: 7
    part of, a judicial proceeding in which he participates as counsel, if it
    has some relation to the proceeding.
    Similarly, under § 587 of the Restatement:
    A party to a private litigation or a private prosecutor or defendant in a
    criminal prosecution is absolutely privileged to publish defamatory
    matter concerning another in communications preliminary to a proposed
    judicial proceeding, or in the institution of or during the course and as a
    part of, a judicial proceeding in which he participates, if the matter has
    some relation to the proceeding.
    In accord with these provisions, statements made before or during a judicial
    proceeding are privileged so long as they are related to the proceeding, and claims
    sounding in defamation for such statements are barred. See Club Valencia
    Homeowners Ass’n, Inc. v. Valencia Assocs., 
    712 P.2d 1024
    , 1025-26, 1028 (Colo.
    App. 1985) (letter written jointly by attorney and his client relating to litigation
    privileged, barring libel claims); Buckhannon v. U.S. W. Commc’ns, Inc., 
    928 P.2d 1331
    , 1333-35 (Colo. App. 1996) (statements by corporate defendant’s investigator,
    attributed to the defendant, absolutely privileged regardless of tort theory); Dep’t of
    Admin., 
    703 P.2d at 597-98
     (statements by party to administrative proceeding
    absolutely privileged). The Colorado Court of Appeals has cautioned, however, that
    “extending the same protection to prelitigation statements as that applied to
    statements made during court proceedings could condone improper behavior while
    doing nothing to advance the goals of the litigation privilege (ensuring access to the
    courts and protection of attorneys during the course of client representation).”
    Begley, 
    399 P.3d at 781
    . The Begley court was concerned that “an attorney could
    make a statement that tortiously interfered with a contract and then cloak it in the
    7
    Appellate Case: 21-1309     Document: 010110699363        Date Filed: 06/21/2022     Page: 8
    privilege by subsequently filing a bad faith and meritless claim related to the
    otherwise tortious statement.” 
    Id.
     Consequently, the court ruled that “for a litigation
    privilege to apply to an attorney’s prelitigation statement, not only must that
    statement be related to prospective litigation, but the litigation must be contemplated
    in good faith.” 
    Id.
     But this good-faith requirement applies to attorneys and parties
    alike. See Restatement § 586 cmt. e (explaining that application of the privilege as to
    attorneys is proper “only when the communication has some relation to a proceeding
    that is contemplated in good faith and under serious consideration”); id. § 587 cmt. e
    (same as to parties).
    Here, the district court rejected OT’s immunity claim for Stevens’ letter, ruling
    that only attorney statements are privileged. The district court also faulted OT for
    failing to cite controlling authority demonstrating that the privilege applies to
    statements by non-attorney parties. But OT cited both sections of the Restatement,
    Club Valencia, Department of Administration, and Buckhannon, all of which confirm
    that the privilege can apply to both attorneys and parties. See, e.g., Club Valencia,
    
    712 P.2d at 1027-28
     (affirming dismissal of libel claim brought against two parties
    and attorney, recognizing the privilege applied to their letter because the purpose of
    the privilege “is to afford litigants the utmost freedom of access to the courts . . . and
    to protect attorneys during the course of their representation of clients” (emphasis
    added)). The district court concluded otherwise, relying on another district court
    case, which in turn quoted Begley’s statement that the litigation privilege protects
    “‘an attorney’s defamatory statements.’” ClearCapital.com, Inc. v. Computershare,
    8
    Appellate Case: 21-1309    Document: 010110699363        Date Filed: 06/21/2022     Page: 9
    Inc., No. 18-cv-00817-RBJ, 
    2019 WL 1573300
    , at *3-4 (D. Colo. Apr. 11, 2019)
    (unpublished) (brackets omitted) (quoting Begley, 
    399 P.3d at 780
    ). But Begley
    should not be read so narrowly because it involved an attorney who was a named
    defendant. See 
    399 P.3d at 780
    . Begley itself recognized that the “litigation
    privilege exists to encourage and protect free access to the courts for litigants and
    their attorneys.” 
    Id.
     (emphasis added). And without restricting its analysis to
    attorneys, Begley observed that statements made by “a party” or one who interferes
    with a contract can be privileged. 
    Id.
     (internal quotation marks omitted).
    Accordingly, because the privilege can apply to attorneys and parties alike, the
    district court should have analyzed all of the Spring 2020 Communications, including
    Stevens’ letter and Neff’s follow-up communications, together. Under that analysis,
    the relevant inquiry is whether OT’s Spring 2020 Communications related to the
    Northern District of Illinois litigation and whether that litigation was contemplated in
    good faith. We thus remand to the district court for proper analysis.
    III. Pendent Jurisdiction
    Finally, OT invokes our pendent jurisdiction to review the district court’s other
    interlocutory rulings: (1) refusing to dismiss Counts 1 and 2 under the Lanham Act
    and the CCPA as unauthorized supplemental pleadings, (2) refusing to dismiss the
    entire amended complaint for impermissibly incorporating allegations to support
    multiple claims, and (3) refusing to dismiss Count 6 as an improper anticipatory
    filing. We conclude that none of these issues warrant review under our pendent
    jurisdiction.
    9
    Appellate Case: 21-1309    Document: 010110699363        Date Filed: 06/21/2022     Page: 10
    Exercise of pendent jurisdiction is discretionary and “only appropriate in either
    of two scenarios: (1) when the otherwise nonappealable decision is inextricably
    intertwined with the appealable decision, or (2) where review of the nonappealable
    decision is necessary to ensure meaningful review of the appealable one.” Cummings
    v. Dean, 
    913 F.3d 1227
    , 1235 (10th Cir. 2019) (internal quotation marks omitted).
    Given these limited scenarios, pendent jurisdiction is “generally disfavored” where,
    as here, the underlying appeal involves an interlocutory question of immunity
    brought under the collateral order doctrine, which “is premised on the ability to
    decide the . . . immunity issue in isolation from the remaining issues of the case.” 
    Id.
    (internal quotation marks omitted).
    Neither scenario exists here. The interlocutory rulings are not inextricably
    intertwined with the question of OT’s immunity. See 
    id. at 1236
     (“A pendent claim
    may be considered ‘inextricably intertwined’ only if it is coterminous with, or
    subsumed in, the claim before the court on interlocutory appeal—that is, when the
    appellate resolution of the collateral appeal necessarily resolves the pendent claim as
    well.” (some internal quotation marks omitted)). And review of the interlocutory
    rulings is unnecessary to ensure meaningful review of the immunity question.
    Indeed, our foregoing analysis confirms it is not. See 
    id.
     We therefore decline to
    exercise pendent jurisdiction over the district court’s remaining interlocutory rulings.
    V. Conclusion
    Vivos’s motion to dismiss this appeal is denied in part and granted in part. To
    the extent the denial of immunity turned on a question of law, the district court’s
    10
    Appellate Case: 21-1309    Document: 010110699363       Date Filed: 06/21/2022   Page: 11
    decision is reversed and remanded for further proceedings. To the extent the denial
    of immunity turned on the factual inadequacy of the record, we dismiss the appeal.
    We decline to exercise pendent jurisdiction over the balance of this appeal.
    Entered for the Court
    Allison H. Eid
    Circuit Judge
    11